Journal of Craniomaxillofacial Research Impact Score 2026

---

The latest ranking of Journal of Craniomaxillofacial Research has been released. Through this web page, researchers can check the ranking, journal quartile, and journal aim & scope.

Journal of Craniomaxillofacial Research: Aim & Scope

Journal of Craniomaxillofacial Research is a indexed journal tha publishes research in the area: Dentistry; Medicine.
The ISSN of this journal is 23456213, 23455489.

Impact Score of Journal of Craniomaxillofacial Research

Journal Title	Journal of Craniomaxillofacial Research
Impact Score	0.1
SJR	0.110
ISSN	23456213, 23455489
Quartile	Q4

Similiar journals to publish

---

Journal of Craniomaxillofacial Research

ISSN: 2345-6213
Journal Impact:
Journal Scope: Medicine

CRANIOMAXILLOFACIAL TRAUMA & RECONSTRUCTION

ISSN: 1943-3883
Journal Impact: 0.8
Journal Scope: Dentistry, Oral Surgery & Medicine

Craniomaxillofacial Trauma & Reconstruction

ISSN: 1943-3883
Journal Impact:
Journal Scope:

Journal of Research and Educational Research Evaluation

ISSN:
Journal Impact:
Journal Scope: Education: Special aspects of education

Journal of Empirical Research on Human Research Ethics

ISSN: 15562654
Journal Impact: 1.7
Journal Scope: Ethics

Mutation Research - Reviews in Mutation Research

ISSN: 13882139
Journal Impact:
Journal Scope: Genetics (Q1); Health, Toxicology and Mutagenesis (Q1)

Deep-Sea Research Part I: Oceanographic Research Papers

ISSN: 9670637
Journal Impact:
Journal Scope: Aquatic Science (Q1); Oceanography (Q1)

DEEP-SEA RESEARCH PART I-OCEANOGRAPHIC RESEARCH PAPERS

ISSN: 1879-0119
Journal Impact: 2.3
Journal Scope: Oceanography

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

ISSN: 1388-2139
Journal Impact: 6.4
Journal Scope: Biotechnology & Applied Microbiology | Genetics & Heredity | Toxicology

Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association (CSA), The

ISSN: 14626446
Journal Impact:
Journal Scope: Medicine (miscellaneous) (Q3)